143
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Effect of Nanoparticles on Digitoxin Uptake and Pharmacologic Activity in Rat Glomerular Mesangial Cell Cultures

Pages 215-222 | Published online: 29 Sep 2008

References

  • Martindale, 1996. The extra pharmacopoei a, 31st ed., 852. London: The Royal Pharmaceutica l Society.
  • Kreuter, J. 1994. Drug targeting with nanoparticles. Eur. J. Drug Metab. Pharmacokin. 19:253– 256.
  • Couvreur, P., Roblot-Treupel, L., Poupon, M. F., Brasseur, F., and Puisieux, F. 1990. Nanoparticles as microcarriers for anticancer drugs. Adv. Drug Del. Rev. 5:209– 230.
  • Leo, E., Arletti, R., Forni, F., and Cameroni, R. 1997. General and cardiac toxicity of doxorubicin-loade d gelatin nanoparticles. Il Farmaco 52:385–388.
  • Maaen, S., Fattal, E., Mu¨ller, R. H., and Couvreur, P. 1993. Cell cultures for the assessment of toxicity and uptake of polymeri c particulate drug carriers. STP Pharma Sci. 3:11–22.
  • Vandorpe, J., Schacht, E., Dunn, S., Hawley, A., Stolnik, S., Davis, S. S., Garnett, M. C., Davies, M. C., and Illum, L. 1997. Long cir- culating biodegradabl e poly(phosphazene) nanoparticle s surface modi- fied with poly(phosphazene)-poly(ethylene oxide) copolymer. Biomaterials 18:1147–1152.
  • Ogawara, K., Yoshida, M., Kubo, J., Nishikawa, M., Takakura, Y., Hashida, M., Higaki, K., and Kimura, T. 1999. Mechanism of hepatic disposition of polystyrene microsphere s in rats: effects of serum depend on the sizes of microspheres. J. Contr. Release 61:241–250.
  • Demoy, M., Andreux, J. P., Weingarten, C., Gouritin, B., Guilloux, V., and Couvreur, P. 1999. Spleen capture of nanoparticles: influence of animal species and surface characteristics. Pharm. Res. 16:37– 41.
  • Demoy, M., Gibaud, S., Andreux, J. P., Weingarten, C., Gouritin, B., and Couvreur, P. 1997. Splenic trapping of nanoparticles: complementar y ap- proaches for in situ studies. Pharm. Res. 14:463–482.
  • Manil, L., Davin, J. C., Duchenne, C., Kubiak, C., Foidart, J., Couvreur, P., and Mahieu, P. 1994. Uptake of nanoparticles by rat glomerular mesangial cells in vivo and in vitro. Pharm. Res. 11:1160–1165.
  • Manil, L., Couvreur, P., and Mahieu, P. 1995. Acute renal toxicity of doxoru- bicin (adriamycin)-loaded cyanoacrylat e nanoparticles. Pharm. Res. 12:85–87.
  • Molpeceres, J., Guzma´n, M., Aberturas, M. R., Chaco´n, M., and Berges, L. 1996. Application of central composite designs to the preparation of poly- caprolactone nanoparticles by solvent displacement. J. Pharm. Sci. 85:206–213.
  • Blanco, G., and Mercer, R. W. 1998. Isoenzymes of the Na-K-ATPase: heterogeneit y in structure, diversity in function. Am. J. Physiol. 275(5Pt2): F633–F650.
  • Striker, G. E., Langer, M. A., Mackay, K., Bernstein, K., and Striker, L. 1987. Glomerular cells in vitro. In The advances in nephrolog y, vol. 16, 169– 185. Necker Hospital, Chicago: Medical Publisher Inc.
  • Scharschmidt, L. A., Douglas, J. G., and Dunn, M. J. 1986. Angiotensin II and eicosanoids in the control of glomerular size in the rat and humans. Am. J. Physiol. 250:F348–F356.
  • Punnonen, E. L., Ryhanen, K., and Marjomaki, V. S. 1998. At reduced temperature, endocytic membrane traffic is blocked in multivesicular carrier endosome s in rat cardiac myocytes. Eur. J. Cell. Biol. 75:344–352.
  • Guise, V., Drouin, J. Y., Benoit, J., Mahuteau, J., Dumont, P., and Couvreur, P. 1990. Vidarabine loaded nanoparticles: a physicochemica l study. Pharm. Res. 7:736–741.
  • USP XXII, 1990, p. 437.
  • Diez-Marque´s, M. L., Garc´õa-Escribano, C., Medina, J., Boyano-Adanez,M. C., Arilla, E., Torrecilla, G., Rodr´õguez-Puyol, D., and Rodr´õguez- Puyol, M. 1995. Effects of somatostatin on cultured mesangial cells. Endocrinology 136(8):3444–3450.
  • Duque, I., Garc´õa-Escribano, C., Rodriguez-Puyol, M., D´õez-Marque´ s,M. L., Lo´pez-Novoa, J. M., Arribas, I., Hernando, L., and Rodriguez-Puyol,D. 1992. Effect of reactive oxygen species on cultured rat mesangial cells and isolated rat glomeruli. Am. J. Physiol. 236: F466–F473.
  • Colin de Verdie´re, A., Dubernet, C., Nemati, F., Poupon, M. F., Puisieux, F., and Couvreur, P. 1994. Uptake of doxorubici n from loaded nanoparticle s in multidrug-resistan t leukemic murine cells. Cancer Chemother. Pharmacol. 33:504–508.
  • Rolland, A., Be´gue´, J. M., Leverge, R., and Guillouzo, A. 1989. Increase of doxorubici n penetration in cultured rat hepatocyte s by its binding to polymethacryli c nanoparticles. Int. J. Pharm. 53:67–73.
  • Yang, Z., Birkenhauer, P., Julmy, F., Chickering, D., Ranieri, J. P., Merkle, H. P., Lu¨scher, T. F., and Gander, B. 1999. Sustained release of heparin from polymeric particles for inhibition of human smooth muscle cell prolifera- tion. J. Contr. Release 60:269–277.
  • Storstein, L. 1981. Pharmacokinetic s of digitoxin. In Handboo k of experi- mental pharmacolog y, vol. 56. Part II: Pharmacokinetics and clinical phar- macology, ed. K. Greff, 4. Berlin: Springer-Verlag.
  • Molpeceres, J., Guzma´n, M., Bustamante, P., and Aberturas, M. R. 1996. Exothermic-endothermi c heat of solution shift of cyclosporin A related to poloxame r 188 behavior in aqueous solutions. Int. J. Pharm. 130:75–81.
  • Rodriguez-Barbero, A., Martinez-Salgado, C., Rodriguez-Lo´pez, A. M., Ricote, M., Sancho, J., and Novoa, J. M. 1995. Effect of hypothalamic - hypophysar y inhibitory factor on mesangial cell activation. Hypertension 26:905–911.
  • Guzma´n, M., Aberturas, M. R., Molpeceres, J., Fessi, H., Puisieux, F., and Devissaguet, J. P. 1990. Nanopart´õculas de poli-epsilon-caprolacton a con digitoxina. I. Estudios de captacio´n. An. Real Acad. Farm. 56:443–452.
  • Aberturas, M. R., Molpeceres, J., Guzma´n, M., Fessi, H., Puisieux, F., and Devissaguet, J. P. 1991. Nanopart´õculas de poli-epsilon-caprolacton a condigitoxina. II. Estabilidad en medios biolo´gicos. An. Real Acad. Farm. 57: 5–14.
  • Lamb, J. F., and Ogden, P. 1982. Internalization of ouabain and replacemen t of sodium pumps in the plasma membranes of HeLa cells following block with cardiac glycosides. Q. J. Exp. Physiol. 67:105–119.
  • Del Moral, R. G., Olmo, A., Aguilar, M., and O’Valle, F. 1998. P- glycoprotein: a new mechanism to control drug-induce d nephrotoxicity. Exp. Nephrol. 6(2):89–97.
  • Emi, Y., Tsunashima, D., Ogawara, K., Higaki, K., and Kimura, T. 1998. Role of P-glycoprotein as a secretory mechanism in quinidine absorption from rat small intestine. J. Pharm. Sci. 87:295– 299.
  • Batrokova, E., Han, H., Alakhov, V., Miller, D., and Kabanov, A. 1998. Effects of pluronic block copolymer s on drug absorption in Caco-2 cells monolayers. Pharm. Res. 15:850–855.
  • Dunn, S., Garnett, M., Davis, S., Davis, M., and Illum, L. 1997. In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanosphere s surface modified by poloxame r and poloxamine copolymers. J. Cont. Release 44:65–76.
  • Neal, J., Stolnik, S., Garnett, M., Davis, S., and Illum, L. 1998. Modifica- tion of the copolymer s poloxame r 407 and poloxamin e 908 can affect the physical and biological properties of surface modified nanospheres. Pharm. Res. 15:318–324.
  • Moore, A., Weissleder, R., and Bogdanov, A. 1997. Uptake of dextran- coated monocrystallin e iron oxides in tumor cells and macrophages. J. Magn. Reson. Imaging 7:1140–1145.
  • Yamamoto, S., Askew, G., Heiny, J., Masaki, H., and Yatani, A. 1996. Modulation of pump function by mutations in the first transmembran e region of Na-K-ATPase a1 -subunit. Am. J. Physiol. 270:C457–C464.
  • Miller, D., Batrakova, E., Waltner, T., Alakhov, V., and Kabanov, V. 1997. Interactions of pluronic block copolymer s with brain microvessel endothe- lial cells: evidence of multiple absorption pathway. Bioconjugate Chem. 8:649–657.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.